ESC & iPSC News Volume 16.45 | Nov 17 2021

    0
    124







    2021-11-17 | ESC 16.45


    ESC & iPSC News by STEMCELL Technologies
    Vol. 16.45 – 17 November, 2021
    TOP STORY

    Single-Cell Transcriptomic Characterization of a Gastrulating Human Embryo

    Researchers characterized, in a spatially resolved manner, the single-cell transcriptional profile of an entire gastrulating human embryo, staged to be between 16 and 19 days after fertilization.
    [Nature]

    AbstractPress Release


    An ISSCR 2021 Innovation Showcase Webinar: Quality by Design in hPSC Cell Therapy, presented by Lynn Csontos & Kimberly Snyder. Click to Watch Now.
    PUBLICATIONSRanked by the impact factor of the journal

    Schizophrenia Is Defined by Cell-Specific Neuropathology and Multiple Neurodevelopmental Mechanisms in Patient-Derived Cerebral Organoids

    Scientists utilized patient-derived iPSCs to generate 3D cerebral organoids to model neuropathology of schizophrenia during its early-arising neurodevelopmental period.
    [Molecular Psychiatry]

    Full Article

    Generation of Functional Ciliated Cholangiocytes from Human Pluripotent Stem Cells

    The authors generated functional human PSC-derived cholangiocytes that displayed many characteristics of mature bile duct cells including high levels of cystic fibrosis transmembrane conductance regulator and the presence of primary cilia capable of sensing flow.
    [Nature Communications]

    Full Article

    A Tissue-Bioengineering Strategy for Modeling Rare Human Kidney Diseases In Vivo

    Generation of kidney organoids from Tuberous Sclerosis Complex patient-derived-human iPSCs allowed investigators to recapitulate a rare kidney tumor called angiomyolipoma.
    [Nature Communications]

    Full Article

    Generation of Heart-Forming Organoids from Human Pluripotent Stem Cells

    Researchers provided a detailed protocol describing how to form heart-forming organoids within 14 days, that could be used on many different human PSC lines and be combined with manipulation technologies such as gene targeting and drug testing.
    [Nature Protocols]

    Abstract

    Erythropoietic Properties of Human iPSC-Derived RBCs in Immunodeficient Mice

    The authors developed a murine model to investigate the in vivo properties of human iPSC-red blood cells (RBCs). iPSC lines were produced from human peripheral blood mononuclear cells by transient expression of plasmids containing OCT4, SOX2, MYC, KLF4 and BCL-XL genes.
    [American Journal of Hematology]

    Abstract

    Defective Chromatin Architectures in Embryonic Stem Cells Derived from Somatic Cell Nuclear Transfer Impair Their Differentiation Potentials

    Investigators employed ATAC-seq and Hi-C techniques to explore the chromatin accessibility and 3D genome organization of nuclear transfer ESCs (ntESCs) and showed that the chromatin accessibility and genome structures of somatic cells were re-arranged to ESC-like states overall in ntESCs.
    [Cell Death & Disease]

    Full Article

    The Distinct Responsiveness of Cytokeratin 19-Positive Hepatocellular Carcinoma to Regorafenib

    Regorafenib preferentially increased the growth inhibition and apoptosis of CK19+ cells in vitro, whereas sorafenib, apatinib, and 5-fluorouracil did not.
    [Cell Death & Disease]

    Full Article

    Mitophagy Mediates Metabolic Reprogramming of Induced Pluripotent Stem Cells Undergoing Endothelial Differentiation

    To evaluate mitophagy during iPSC differentiation, researchers performed live-cell imaging of mitochondria and lysosomes in human iPSCs differentiating into vascular endothelial cells using confocal microscopy.
    [Journal of Biological Chemistry]

    Full Article

    Transcriptional Changes and the Role of ONECUT1 in hPSC Pancreatic Differentiation

    Scientists analyzed stage-specific RNA-, ChIP-, and ATAC-sequencing data to dissect transcriptional and regulatory mechanisms during pancreatic development.
    [Communications Biology]

    Full Article

    An ERK5-KLF2 Signaling Module Regulates Early Embryonic Gene Expression and Telomere Rejuvenation in Stem Cells

    The authors employed quantitative proteomic profiling to identify proteins whose expression was regulated by the ERK5 pathway in mouse ESCs, revealing a function for ERK5 signaling in regulating dynamically expressed early embryonic 2-cell stage genes.
    [Biochemical Journal]

    Abstract

    A Selectable All-in-One CRISPR Prime Editing piggyBac Transposon Allows for Highly Efficient Gene Editing in Human Cell Lines

    Investigators demonstrated proof-of-concept for piggyBac prime-editing in a newly designed lentiviral traffic light reporter, which allowed for estimation of gene correction and defective editing resulting in indels, based on expression of two different fluorophores.
    [Scientific Reports]

    Full Article

    Identification of ASCL1 as a Determinant for Human iPSC-Derived Dopaminergic Neurons

    Differentiation platforms were established to model neural induction from stem cells, and scientists characterized these differentiated cell types by 10x single cell RNA sequencing.
    [Scientific Reports]

    Full Article

    Survey results on the insights and hurdles of CRISPR genome editing.
    REVIEWS

    DPPA2, DPPA4, and Other DPPA Factor Epigenomic Functions in Cell Fate and Cancer

    The authors highlight an important regulatory role for DPPA2 and DPPA4 at the transitional boundary between pluripotency and differentiation, and discuss their functions in the context of cancer cells.
    [Stem Cell Reports]

    Full Article

    INDUSTRY AND POLICY NEWS

    Prilenia Receives Fast Track Designation for Pridopidine for the Treatment of Huntington’s Disease

    Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, announced that the US FDA has granted Fast Track designation to pridopidine for development as a potential treatment for Huntington’s Disease.
    [Prilenia Therapeutics B.V.]

    Press Release

    FEATURED EVENT

    Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

    February 2 – 6, 2022
    Salt Lake City, Utah, United States

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Cancer, Immunity, and Stem Cell Biology

    UC San Diego Health – La Jolla, California, United States

    Clinical Operations Manager – Clinical Research

    NUI Galway – Galway, Ireland

    Automation Scientist – Modeling Pediatric Diseases

    St. Jude Children’s Research Hospital – Memphis, Tennessee, United States

    Researcher – Organoid Models for Drug Discovery

    KU Leuven – Leuven, Brussels

    Postdoctoral Research Fellow – Mammalian Synthetic Biology and Organoid Engineering

    The University of British Columbia – Vancouver, British Columbia, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    ESC & iPSC News Twitter